THE WOODLANDS, Texas--( BUSINESS WIRE )-- Pernix Therapeutics Holdings, Inc. ("Pernix" or the "Company") ( NAS: PTX ), a specialty pharmaceutical company, today announced financial results for the fourth quarter and year ended December 31, 2012.